DE69408122T2 - Zusammensetzung aus mikropartikeln in verdichteter phase und verfahren - Google Patents

Zusammensetzung aus mikropartikeln in verdichteter phase und verfahren

Info

Publication number
DE69408122T2
DE69408122T2 DE69408122T DE69408122T DE69408122T2 DE 69408122 T2 DE69408122 T2 DE 69408122T2 DE 69408122 T DE69408122 T DE 69408122T DE 69408122 T DE69408122 T DE 69408122T DE 69408122 T2 DE69408122 T2 DE 69408122T2
Authority
DE
Germany
Prior art keywords
microparticles
composition
compressed phase
disclosed
phase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69408122T
Other languages
English (en)
Other versions
DE69408122D1 (de
Inventor
Julio M Fernandez
Mark B Knudson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mayo Foundation for Medical Education and Research
Original Assignee
Mayo Foundation for Medical Education and Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mayo Foundation for Medical Education and Research filed Critical Mayo Foundation for Medical Education and Research
Application granted granted Critical
Publication of DE69408122D1 publication Critical patent/DE69408122D1/de
Publication of DE69408122T2 publication Critical patent/DE69408122T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5176—Compounds of unknown constitution, e.g. material from plants or animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1664—Compounds of unknown constitution, e.g. material from plants or animals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/585—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
    • G01N33/586—Liposomes, microcapsules or cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Botany (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Dispersion Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE69408122T 1993-02-12 1994-02-10 Zusammensetzung aus mikropartikeln in verdichteter phase und verfahren Expired - Fee Related DE69408122T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1768193A 1993-02-12 1993-02-12
PCT/US1994/001924 WO1994017786A1 (en) 1993-02-12 1994-02-10 Condensed-phase microparticle composition and method

Publications (2)

Publication Number Publication Date
DE69408122D1 DE69408122D1 (de) 1998-02-26
DE69408122T2 true DE69408122T2 (de) 1998-09-03

Family

ID=21783984

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69408122T Expired - Fee Related DE69408122T2 (de) 1993-02-12 1994-02-10 Zusammensetzung aus mikropartikeln in verdichteter phase und verfahren

Country Status (9)

Country Link
EP (1) EP0684812B1 (de)
JP (1) JPH08509956A (de)
AT (1) ATE162397T1 (de)
AU (1) AU676543B2 (de)
CA (1) CA2155648C (de)
DE (1) DE69408122T2 (de)
DK (1) DK0684812T3 (de)
ES (1) ES2114184T3 (de)
WO (1) WO1994017786A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9320668D0 (en) 1993-10-07 1993-11-24 Secr Defence Liposomes containing particulare materials
CA2193954A1 (en) 1994-06-27 1996-01-04 Vu L. Truong Targeted gene delivery system
JP2000514440A (ja) * 1996-07-09 2000-10-31 ザ ジョーンズ ホプキンス ユニバーシティー 遺伝子輸送システム
JP4335316B2 (ja) * 1996-09-19 2009-09-30 ザ・リージェンツ・オブ・ザ・ユニバーシティ・オブ・ミシガン アルギネートまたは修飾アルギネートのようなポリサッカライドを含むポリマー
WO1999038978A1 (en) 1998-01-31 1999-08-05 University Of Arkansas Methods and reagents for decreasing allergic reactions
US7879977B2 (en) 1998-01-31 2011-02-01 University Of Arkansas Methods and reagents for decreasing clinical reaction to allergy
US5952232A (en) * 1998-09-17 1999-09-14 Rothman; James Edward Expandible microparticle intracellular delivery system
DE19943429A1 (de) * 1999-09-08 2001-03-15 Beiersdorf Ag Kosmetische und dermatologische Zubereitungen mit einem Gehalt an sulfonierten Kammpolymeren
DK1272213T3 (da) 2000-04-06 2006-07-10 Seer Pharmaceuticals Llc Mikrobielt afgivelsessystem
US8246945B2 (en) 2000-04-06 2012-08-21 University Of Arkansas Methods and reagents for decreasing clinical reaction to allergy
US20030138975A1 (en) * 2001-12-20 2003-07-24 Kimberly-Clark Worldwide, Inc. Diagnostic signal amplification with proteinoid microspheres
US7056535B2 (en) 2001-12-20 2006-06-06 Kimberly-Clark Worldwide, Inc. Triggered release from proteinoid microspheres

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI84874C (fi) * 1989-11-02 1992-02-10 Valio Meijerien Foerfarande foer inkapsling av biologiskt aktiva aemnen, enligt metoden framstaelld kapsel, dess anvaendning och foder innehaollande den.
US5149543A (en) * 1990-10-05 1992-09-22 Massachusetts Institute Of Technology Ionically cross-linked polymeric microcapsules
FR2677249B1 (fr) * 1991-06-04 1995-03-17 Biovecteurs As Vecteur particulaire biodegradable et procede de synthese.

Also Published As

Publication number Publication date
WO1994017786A1 (en) 1994-08-18
CA2155648C (en) 1999-05-11
EP0684812B1 (de) 1998-01-21
ATE162397T1 (de) 1998-02-15
DK0684812T3 (da) 1998-09-21
JPH08509956A (ja) 1996-10-22
AU676543B2 (en) 1997-03-13
ES2114184T3 (es) 1998-05-16
EP0684812A1 (de) 1995-12-06
DE69408122D1 (de) 1998-02-26
AU6247994A (en) 1994-08-29
CA2155648A1 (en) 1994-08-18

Similar Documents

Publication Publication Date Title
DE69531741D1 (de) Verbindungen und zusammensetzungen zur verabreichung aktiver stoffe
DE69408122D1 (de) Zusammensetzung aus mikropartikeln in verdichteter phase und verfahren
ATE383169T1 (de) Komponente und zusammensetzungen zur verabreichung von wirkstoffen
MD960330A (ro) Compuşi nepeptidilici, compoziţie farmaceutică pe baza acestora, metodă de tratament
DE59409568D1 (de) Wirkstoffe und gas enthaltende mikropartikel
HK1097449A1 (en) Methods for in vivo delivery of biologics and compositions useful therefor
DE60226613D1 (de) Darreichungsformen welche mikropartikel und treibgas enthalten
PL314187A1 (en) Novel derivatives of pyrazine carboxamide, method of obtaining them and their application in pharmaceutical composition
HK1021539A1 (en) Androstene derivatives.
ATE363899T1 (de) Pharmazeutische zusammensetzungen mit modafinil
ES2168457T3 (es) Composiciones farmaceuticas que comprenden una superoxido dismutasa.
DE69922017D1 (de) Arzneimittel und verfahren zur behandlung von intrazellulären infektionen
DE4495520T1 (de) Verfahren und pharmazeutische Zusammensetzung zum zielgerichten Anwenden von Wirkstoffen
KR950701924A (ko) 신규한 생물학적으로 활성인 에부르나메닌 유도체 및 그 유도체가 함유된 약제학적 조성물과 그 제조방법
ATE302210T1 (de) Histogranin peptide und deren analgetische verwendung
EP0683668A4 (de) Präparate und verfahren für eine transdermale arzneistoffverabreichung.
HRP20000781B1 (en) Effervescent preparations
GEP20032975B (en) Echinocandin Derivatives, Preparation Method and Pharmaceutical Composition
BG103905A (en) New bpc peptide salts with organoprotective activity, method for their preparation and application in medicine
DE69230644D1 (de) Verwendung von protease nexin-i als mittel gegen entzündungen
HK1029277A1 (en) Pharmaceutical coating composition and method of use.
ATE148451T1 (de) Ng-monomethyl-l-arginin-hydrochlorid-derivate und verfahren zu deren herstellung
DK8291A (da) Praeparat omfattende en aktiv bestanddel, fortrinsvis i pulver- eller partikelform, samt en baerer for den aktive bestanddel og fremgangsmaade til fremstilling af et saadant praeparat
IL109730A0 (en) Methods for administering biological agents and microparticle compositions useful in these and other methods
IT1254452B (it) N-ossidi ed n,n'-diossidi di 3-(piperazin-1-il)-propan-1,2-dioli

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee